A significant breakthrough in cancer study is emerging with the use of VHH fragments to re-engage damaged p53. This vital malignant inhibitor protein is frequently inactivated in several kinds of malignancies, causing https://socialimarketing.com/story7586254/vhh-fragments-reactivate-p53-the-new-hope-for-tumor-management